General Information
|
|
Product
|
Phospho-p27 KIP1 Peptide
|
Description
|
Antigenic Blocking Peptide Phosphorylated Cyclin-dependent kinase inhibitor p27kip1 Antibody Extreme C-epitope
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
Peptide Description
|
Synthetic peptide taken within amino acid region 148-198 on human Cyclin-dependent kinase inhibitor 1 (p27, KIP1) protein.
|
Accession #
|
GenBank: AAH01971.1
|
Physical Properties
|
|
Quantity
|
250 µg
|
Volume
|
100 µl
|
Form
|
Antigenic Blocking Peptide
|
Determinant
|
Extreme C-epitope
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
Protein
|
Uniprot #
|
Q9NYG6
|
Overview
|
Important regulator of cell cycle progression. Involved in G1 arrest. Potent inhibitor of cyclin E- and cyclin A-CDK2 complexes. Forms a complex with cyclin type D-CDK4 complexes and is involved in the assembly, stability, and modulation of CCND1-CDK4 complex activation. Acts either as an inhibitor or an activator of cyclin type D-CDK4 complexes depending on its phosphorylation state and/or stoichometry.
|
Molecular Function
|
Cyclin-dependent protein serine/threonine kinase inhibitor activity, kinase activity
|
Subcellular Location
|
Nucleus
|
Expression
|
Expressed in all tissues tested. Highest levels in skeletal muscle, lowest in liver and kidney.
|
Structure
|
Forms a ternary complex with CCNE1/CDK2/CDKN1B. Interacts directly with CCNE1; the interaction is inhibited by CDK2-dependent phosphorylation on Thr-187. Interacts with COPS5, subunit of the COP9 signalosome complex.
|
Alternative Nomenclature
|
AA408329 antibody
AI843786 antibody
CDKN 1B antibody
CDKN 4 antibody
Cyclin Dependent Kinase Inhibitor 1B antibody
Cyclin dependent kinase inhibitor p27 antibody
KIP 1 antibody
MEN1B antibody
MEN4 antibody
p27 antibody
p27 Kip1 antibody
P27-like cyclin-dependent kinase inhibitor antibody
|
|
|